| Word Search (Top 10 - by date) |
ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)
IR Biosciences Holdings
(September 08, 2010)
|
GSK and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-Hodgkin’s Lymphoma
Genmab
(September 08, 2010)
|
GlaxoSmithKline and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-hodgkin’s Lymphoma
GlaxoSmithKline
(September 08, 2010)
|
Anti-Angiogenic Anti-Cancer Agent Avastin® Condition for Approval (All Patients Surveillance) Removed in Japan
Chugai
(September 08, 2010)
|
Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan
Onyx Pharmaceuticals
(September 08, 2010)
|
Ono Announces Carfilzomib Development and Commercialization Agreement with Onyx Pharmaceuticals for Japan
Ono Pharmaceutical
(September 08, 2010)
|
New Patents Expand Coverage for Imaging and Therapeutic Applications of Peregrine's Phospholipid-Targeting Technologies
Peregrine Pharmaceuticals
(September 07, 2010)
|
Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
Seattle Genetics
(September 02, 2010)
|
MorphoSys Initiates Program Against Drug-Resistant MRSA Infections
MorphoSys
(September 02, 2010)
|
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Astellas Pharma
(September 01, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|